These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4453700)

  • 1. [Action of the essentiale preparation-an injectable solution-on the syndrome of persistent hepatic cytolysis].
    Brauner F; Cercel I; Duda R; Zilberman L; Roman D
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):707-9. PubMed ID: 4453700
    [No Abstract]   [Full Text] [Related]  

  • 2. [The product "Essentiale" in therapy of acute epidemic hepatitis].
    Căruntu V; Voiculescu M; Perederi L; Roşca M; Dună F
    Med Interna (Bucur); 1973 May; 25(5):573-81. PubMed ID: 4136123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study on the treatment of liver disease with glucocorticoids].
    Oda T; Suzuki H; Naito C; Yamanada M; Oka H
    Saishin Igaku; 1969 Oct; 24(10):2119-29. PubMed ID: 5349229
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-statistical study of the therapeutic activity of coenzyme A in various hepatopathies].
    Ruberti A; Tobaldin G; Montanari MG; Castellani P
    Clin Ter; 1971 May; 57(4):309-42. PubMed ID: 5110947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of anabolizing steroids on BSP excretion in healthy subjects and in patients with liver diseases in the second and third stages of childhood].
    D'Avanzo M; Tiberio P; Lupi L
    Pediatria (Napoli); 1968 Mar; 76(1):113-23. PubMed ID: 5738512
    [No Abstract]   [Full Text] [Related]  

  • 6. [Corticosteroid therapy in hepatic diseases].
    Mazzacca G
    Recenti Prog Med; 1967 Jul; 43(1):51-70. PubMed ID: 4302862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reflections on prednisone therapy of patients with liver diseases].
    Teichmann W
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucocorticotherapy in hepatic diseases].
    Boroń P; Borzuchowska A; Modzelewski T
    Przegl Lek; 1970; 26(10):753-5. PubMed ID: 5484242
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical and biological effectiveness of citiolone and importance of its contribution in hepatic therapeutics].
    Duché G
    Therapeutique; 1970 Dec; 46(10):1037-41. PubMed ID: 5511931
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of citiolone, cyto-membranous hepatic protector].
    Varay A; Castel A; Bloch J
    Therapeutique; 1970 Dec; 46(10):993-5. PubMed ID: 5511936
    [No Abstract]   [Full Text] [Related]  

  • 11. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Essentiale" in the treatment of liver diseases].
    Blaser E
    Schweiz Arch Tierheilkd; 1968 Nov; 110(11):582-7. PubMed ID: 5753485
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evolution of chronic diffuse liver diseases treated by essential choline phospholipid therapy. Clinical and analytical control through exploration with radioactive isotopes].
    Galán Navarro JL
    Rev Esp Enferm Apar Dig; 1967 Apr; 26(4):460-90. PubMed ID: 5603013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic utilization of fructose in liver diseases].
    Horecká J
    Cesk Gastroenterol Vyz; 1969 Mar; 23(2):74-7. PubMed ID: 5768480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trial of coenzyme A in hepatopathies].
    Magaraci G
    Minerva Med; 1976 Feb; 67(8):512-8. PubMed ID: 943732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of high-dose, intravenous and oral administration of essential phospholipids on protein and lipid metabolism as well as enzyme activities in patients with chronic liver disease].
    Müting D; Dohn P; Reikowski J
    Verh Dtsch Ges Inn Med; 1972; 78():1389-92. PubMed ID: 4665555
    [No Abstract]   [Full Text] [Related]  

  • 19. [Essential phospholipids for therapy in liver diseases].
    Wallnöfer H; Hanusch M
    Med Monatsschr; 1973 Mar; 27(3):131-6. PubMed ID: 4725226
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic liver diseases with thioctic acid].
    Möller E; Brinkmann W; Weber O; Wildhirt E
    Med Klin; 1967 Mar; 62(10):380-4. PubMed ID: 4874626
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.